VANDA PHARMACEUTICALS INC

Ticker: VNDA CUSIP: 921659108 Class: Common Stock

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022

Shares 12,821 Value ($000) $95 Avg Close $9.74 Range $6.73 - $11.04

Q3 2022

Shares 23,155 Value ($000) $229 Avg Close $10.56 Range $9.34 - $11.90

Q2 2022

Shares 76,063 Value ($000) $829 Avg Close $10.36 Range $9.24 - $12.06

Q1 2022

Shares 239,627 Value ($000) $2,710 Avg Close $13.15 Range $10.60 - $16.93

Q4 2021

Shares 120,298 Value ($000) $1,887 Avg Close $17.43 Range $15.55 - $21.44

Q3 2021

Shares 125,417 Value ($000) $2,150 Avg Close $17.51 Range $15.13 - $21.86

Q2 2021

Shares 133,411 Value ($000) $2,870 Avg Close $17.89 Range $15.05 - $21.84

Q1 2021

Shares 136,758 Value ($000) $2,054 Avg Close $16.19 Range $13.14 - $20.51

Q4 2020

Shares 133,389 Value ($000) $1,753 Avg Close $12.04 Range $9.62 - $14.02

Q3 2020

Shares 69,548 Value ($000) $672 Avg Close $10.69 Range $9.00 - $12.49

Q2 2020

Shares 34,206 Value ($000) $391 Avg Close $11.32 Range $9.55 - $12.33

Q1 2020

Shares 28,287 Value ($000) $293 Avg Close $12.40 Range $7.12 - $16.96

Q4 2019

Shares 27,479 Value ($000) $451 Avg Close $15.12 Range $12.32 - $17.85

Q3 2019

Shares 14,286 Value ($000) $190 Avg Close $13.94 Range $11.83 - $17.00

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2022	12,821	$95	$9.74	$6.73 - $11.04
Q3 2022	23,155	$229	$10.56	$9.34 - $11.90
Q2 2022	76,063	$829	$10.36	$9.24 - $12.06
Q1 2022	239,627	$2,710	$13.15	$10.60 - $16.93
Q4 2021	120,298	$1,887	$17.43	$15.55 - $21.44
Q3 2021	125,417	$2,150	$17.51	$15.13 - $21.86
Q2 2021	133,411	$2,870	$17.89	$15.05 - $21.84
Q1 2021	136,758	$2,054	$16.19	$13.14 - $20.51
Q4 2020	133,389	$1,753	$12.04	$9.62 - $14.02
Q3 2020	69,548	$672	$10.69	$9.00 - $12.49
Q2 2020	34,206	$391	$11.32	$9.55 - $12.33
Q1 2020	28,287	$293	$12.40	$7.12 - $16.96
Q4 2019	27,479	$451	$15.12	$12.32 - $17.85
Q3 2019	14,286	$190	$13.94	$11.83 - $17.00